Related Experiment Video
Updated: Jun 9, 2025

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
Targeting chaperone modifications: Innovative approaches to cancer treatment
Mariah Stewart1, Jonathan C Schisler2
1The McAllister Heart Institute and Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract:
Cancer and other chronic diseases are marked by alterations in the protein quality control system, affecting the posttranslational destiny of various proteins that regulate, structure, and catalyze cellular processes. Cellular chaperones, also known as heat shock proteins (HSPs), are pivotal in this system, performing protein triage that often determines the fate of proteins they bind to. Grasping the regulatory mechanisms of HSPs and their associated cofactors is crucial for understanding protein quality control in both healthy and diseased states. Recent research has shed light on the interactions within the protein quality control system and how post-translational modification govern protein interactions, function, and localization, which can drive or inhibit cell proliferation. This body of work encompasses critical elements of the heat shock response, including heat shock protein 70, heat shock protein 90, carboxyl-terminus of HSC70 interacting protein, and heat shock protein organizing protein. This review aims to synthesize these advancements, offering a holistic understanding of the system and its response when commandeered by diseases like cancer. We focus on the mechanistic shift in co-chaperone engagement-transitioning from heat shock protein organizing protein to carboxyl-terminus of HSC70 interacting protein in association with heat shock protein 70 and heat shock protein 90-which could influence cellular growth and survival pathways. A comprehensive examination of posttranslational modification-driven regulation within the protein quality control network is presented, highlighting the roles of activation factors, chaperones, and co-chaperones. Our insights aim to inform new strategies for therapeutically targeting diseases by considering the entire heat shock response system.
Insights
Altered protein quality control, involving heat shock proteins (HSPs), impacts chronic diseases like cancer. Understanding HSP regulation and co-chaperone shifts offers new therapeutic targets for disease.
Area of Science:
- Cellular Biology
- Molecular Medicine
- Biochemistry
Background:
- Protein quality control systems are crucial for cellular function and are often dysregulated in diseases like cancer.
- Heat shock proteins (HSPs) are key regulators within this system, influencing protein fate and cellular processes.
- Understanding HSPs and their cofactors is vital for comprehending healthy and diseased cellular states.
Purpose of the Study:
- To synthesize recent advancements in the protein quality control system, focusing on heat shock proteins.
- To elucidate the regulatory mechanisms of HSPs and their cofactors in health and disease.
- To explore how post-translational modifications govern protein interactions and cellular proliferation.
Main Methods:
- Review of current literature on heat shock response and protein quality control.
- Analysis of interactions between HSPs (HSP70, HSP90) and co-chaperones (CHIP, HOP).
- Examination of post-translational modifications influencing the protein quality control network.
Main Results:
- Identified a mechanistic shift in co-chaperone engagement (HOP to CHIP) with HSP70 and HSP90.
- Demonstrated how this shift influences cellular growth and survival pathways.
- Highlighted the role of post-translational modifications in regulating activation factors, chaperones, and co-chaperones.
Conclusions:
- Dysregulation of the protein quality control system, particularly HSPs, is implicated in cancer.
- The shift in co-chaperone engagement represents a critical regulatory event affecting cell proliferation.
- Targeting the heat shock response system holistically may offer novel therapeutic strategies for cancer and other diseases.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

